3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Follicular
10
Sarcoma
6
Lymphoma, Non-Hodgkin
5
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, B-Cell
4
Rhabdoid Tumor
3
Prostatic Neoplasms
3
Wilms Tumor
2
Sarcoma, Synovial
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell
2
Lymphoma
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Central Nervous System Neoplasms
2
Xanthogranuloma, Juvenile
1
Urinary Bladder Neoplasms
1
Tertiary Lymphoid Structures
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Recurrence
1
Pancreatic Neoplasms
1
Interventions
Nivolumab
70
pembrolizumab
69
cabozantinib
46
Ipilimumab
38
Specimen Handling
33
Magnetic Resonance Spectroscopy
33
lenvatinib
26
Axitinib
25
belzutifan
21
Sunitinib
18
Biopsy
15
Radiosurgery
14
CTLA-4 Antigen
13
atezolizumab
12
Everolimus
10
pazopanib
8
fludarabine
8
avelumab
8
Bevacizumab
8
toripalimab
7
cemiplimab
7
Nephrectomy
7
Immunoglobulin G
7
Cyclophosphamide
7
aldesleukin
6
Standard of Care
6
Radiotherapy
6
Blood Specimen Collection
6
spartalizumab
5
palbociclib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
tazemetostat
×
1 year
×
Clear all
No trials found.